HomeVIRX • NASDAQ
add
Viracta Therapeutics Inc
Previous close
$0.19
Day range
$0.17 - $0.20
Year range
$0.13 - $1.31
Market cap
7.30M USD
Avg Volume
3.87M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.18M | -18.36% |
Net income | -10.55M | 16.25% |
Net profit margin | — | — |
Earnings per share | -0.27 | 18.18% |
EBITDA | -10.08M | 18.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.13M | -66.52% |
Total assets | 21.96M | -66.95% |
Total liabilities | 28.58M | -21.56% |
Total equity | -6.62M | — |
Shares outstanding | 39.74M | — |
Price to book | -1.10 | — |
Return on assets | -95.58% | — |
Return on capital | -160.22% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.55M | 16.25% |
Cash from operations | -7.09M | 32.67% |
Cash from investing | 8.16M | -10.31% |
Cash from financing | -1.92M | — |
Net change in cash | -854.00K | 40.57% |
Free cash flow | -3.20M | 45.77% |
About
Founded
1998
Website
Employees
26
